This is a preview of subscription content, log in via an institution to check access.
References
Herlopian A, Dietrich J, Abramson JS, Cole AJ, Westover MB (2018) EEG findings in CAR T-cell therapy-related encephalopathy. Neurology 91(5):227–229. https://doi.org/10.1212/WNL.0000000000005910
Ludlow CL, Loucks T (2003) Stuttering: a dynamic motor control disorder. J Fluen Disord 28:273–295. https://doi.org/10.1016/j.jfludis.2003.07.001
Neelapu SS, Tummala S, Kebriaei P, Wierda W, Gutierrez C, Locke FL, Shpall EJ (2018) Chimeric antigen receptor T-cell therapy-assessment and management of toxicities. Nat Rev Clin Oncol. https://doi.org/10.1038/nrclinonc.2017.148
Porter DL, Hwang WT, Frey NV, Lacey SF, Shaw PA, Loren AW, June CH (2015) Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aac5415
Funding
No funding sources.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Gonzalez Castro declares that he has no conflict of interest. Dr. Dietrich declares that he has no conflict of interest. Dr. Forst declares that she has no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Gonzalez Castro, L.N., Dietrich, J. & Forst, D.A. Stuttering as the first sign of CAR-T-cell-related encephalopathy syndrome (CRES). J Cancer Res Clin Oncol 145, 1917–1918 (2019). https://doi.org/10.1007/s00432-018-2818-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-018-2818-y